Corteva, Inc. $CTVA Shares Bought by CIBC Asset Management Inc

CIBC Asset Management Inc boosted its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 65.1% in the 4th quarter, Holdings Channel.com reports. The fund owned 166,264 shares of the company’s stock after buying an additional 65,563 shares during the quarter. CIBC Asset Management Inc’s holdings in Corteva were worth $11,145,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. JPL Wealth Management LLC purchased a new position in Corteva in the third quarter valued at $25,000. Redmont Wealth Advisors LLC purchased a new position in Corteva in the third quarter valued at $29,000. Jackson Grant Investment Advisers Inc. lifted its holdings in Corteva by 90.6% during the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after buying an additional 213 shares during the last quarter. Basepoint Wealth LLC purchased a new stake in Corteva during the 4th quarter worth about $30,000. Finally, Measured Wealth Private Client Group LLC purchased a new stake in Corteva during the 3rd quarter worth about $33,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a report on Friday, February 20th. Wall Street Zen downgraded Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. UBS Group lifted their price target on Corteva from $88.00 to $90.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. CICC Research lifted their price target on Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Finally, Jefferies Financial Group lifted their price target on Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. Fourteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, Corteva has an average rating of “Moderate Buy” and an average target price of $88.67.

Corteva Price Performance

Shares of CTVA opened at $77.06 on Friday. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $85.63. The stock’s 50 day moving average is $81.17 and its two-hundred day moving average is $74.94. The firm has a market capitalization of $51.54 billion, a PE ratio of 45.33, a P/E/G ratio of 2.37 and a beta of 0.57. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. During the same quarter in the previous year, the company earned $1.13 EPS. The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s payout ratio is currently 42.35%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.